Isolation of specific single chain antibodies against three immunodominant epitops of HER-2 antigen for immunotherapy of breast cancer
- سال انتشار: 1394
- محل انتشار: یازدهمین کنگره بین المللی سرطان پستان
- کد COI اختصاصی: ICBCMED11_132
- زبان مقاله: انگلیسی
- تعداد مشاهده: 369
نویسندگان
Recombinant antibody laboratory, Dept. of Immunology, Shiraz University of Medical Sciences, Shiraz, Iran
Shiraz HIV/AIDS research center, Shiraz University of Medical Sciences, Shiraz, Iran
چکیده
Introduction: Breast cancer is the most common cancer among women. Overexpression of human epidermal growth factor receptor 2 (HER2), a cell membrane receptor tyrosine kinase, in breast cancer is often associated with advanced disease and poor prognosis. Recombinant single-chain antibodies (scFvs) which are composed of VH and VL domains, have been introduced as effective alternatives to full-length antibodies in cancer-targeted therapy. In this study we selected specific scFvs against immunodominant epitopes of HER-2 and evaluated the reactivity of the selected scFvs with the corresponding epitopes. Methods: A phage antibody display library of scFv was used for selection of specific scFvs against three HER2 epitopes using panning process. PCR and DNA fingerprinting were applied to show the common patterns and isolation specific clones. The specificity of the clones were tested with ELISA. Results: Four specific clones were selected against three epitopes of HER2 with the frequencies 25%, 45%. 25% and 25%. The ELISA test demonstrated that the selected scFvs reacted with the corresponding epitopes significantly higher than the negative controls. Conclusion: Immunotherapy is a new strategy against different cancers. The human anti-mouse antibody response (HAMA) has reduced the efficacy of the monoclonal Abs. Due to scFvs properties including human origin, high specificity and affinity, these antibodies are useful agents for cancer immunotherapy. In this study four specific scFVs were selected against HER2 antigen. The specificity of the selected scFvs was shown in ELISA. This study suggests further investigation of the selected scFvs for their clinical use.کلیدواژه ها
ScFv, HER2, Immunotherapyمقالات مرتبط جدید
اطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.